Mobile

A Study to Estimate the Immune Response Following a Challenge Dose in Adults (≥ 50 years old) Vaccinated With a Primary Series of an Hepatitis B Vaccine

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-016721-33

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To describe the Seroprotection rate (SPR) at least 2 years following completion of a primary series of modified process RECOMBIVAX HB™ ( HBVaxPRO) and 1 month following a challenge dose of modified process RECOMBIVAX HB™ To describe the Seroprotection rate (SPR) at least 2 years following completion of a primary series of ENGERIX-B™ and 1 month following a challenge dose of modified process RECOMBIVAX HB™.

Critère d'inclusion

  • Healthy subjects, active immunisation against Hepatitis B

Liens